EUVIMEDEUVIMED entdecken
EditorialKommentar

Bridging the Evidence Gap: Sotrovimab Use in Pregnancy and the Need for Comprehensive Drug Safety Data

Ursula Winterfeld

Drug Safety · 2024

DOI: 10.1007/s40264-024-01457-x ↗

Kurz gefasst

Editorial in der Zeitschrift Drug Safety, 2024. Verfasst von Ursula Winterfeld. Beteiligte Einrichtung: Swiss Teratogen Information Service (STIS) and Clinical Pharmacology Service, Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois …. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedHumansPregnancyFemalePregnancy ComplicationsEvidence Gaps

Substanzen

Antibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Swiss Teratogen Information Service (STIS) and Clinical Pharmacology Service, Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland. ursula.winte…

Zitieren

APA

Winterfeld, U. (2024). Bridging the Evidence Gap: Sotrovimab Use in Pregnancy and the Need for Comprehensive Drug Safety Data. Drug Safety. https://doi.org/10.1007/s40264-024-01457-x

Vancouver

Winterfeld U. Bridging the Evidence Gap: Sotrovimab Use in Pregnancy and the Need for Comprehensive Drug Safety Data. Drug Safety. 2024. doi:10.1007/s40264-024-01457-x

BibTeX
@article{Winterfeld2024,
  author = {Winterfeld, Ursula},
  title = {Bridging the Evidence Gap: Sotrovimab Use in Pregnancy and the Need for Comprehensive Drug Safety Data},
  journal = {Drug Safety},
  year = {2024},
  doi = {10.1007/s40264-024-01457-x}
}
Kostenlos starten →